HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Ting-Yu Lin Selected Research
Ting-Yu Lin Research Topics
Disease
16
Neoplasms (Cancer)
05/2024 - 11/2012
9
COVID-19
03/2024 - 12/2020
6
Inflammation (Inflammations)
06/2022 - 03/2006
5
Infections
12/2023 - 01/2020
5
Asthma (Bronchial Asthma)
01/2023 - 01/2013
4
Pain (Aches)
11/2023 - 06/2008
4
Hypotension (Low Blood Pressure)
04/2022 - 01/2011
3
Colorectal Neoplasms (Colorectal Cancer)
05/2024 - 01/2018
3
Chronic Obstructive Pulmonary Disease (COPD)
02/2023 - 06/2013
3
Body Weight (Weight, Body)
02/2022 - 11/2017
3
Malaria
01/2021 - 01/2015
3
Cataract (Cataracts)
01/2020 - 04/2017
3
Ovarian Neoplasms (Ovarian Cancer)
10/2019 - 01/2015
3
Hepatocellular Carcinoma (Hepatoma)
01/2019 - 01/2009
3
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2017 - 01/2011
3
Hypoxia (Hypoxemia)
01/2013 - 07/2010
2
Stroke (Strokes)
02/2023 - 01/2023
2
Heart Failure
12/2022 - 01/2009
2
Stomach Neoplasms (Stomach Cancer)
11/2022 - 08/2021
2
Huntington Disease (Huntington's Disease)
07/2022 - 02/2022
2
Neurodegenerative Diseases (Neurodegenerative Disease)
02/2022 - 11/2020
2
Obstructive Sleep Apnea
01/2022 - 09/2015
2
Hypoventilation
02/2020 - 01/2017
2
Lung Neoplasms (Lung Cancer)
11/2017 - 01/2013
1
Metabolic Syndrome (Dysmetabolic Syndrome X)
05/2024
1
Pathologic Processes
11/2023
1
Hypertension (High Blood Pressure)
06/2023
1
Respiratory Insufficiency (Respiratory Failure)
01/2023
1
Respiratory Syncytial Virus Infections
12/2022
1
Neurodevelopmental Disorders
12/2022
1
Acute Kidney Injury (Acute Renal Failure)
12/2022
1
Intellectual Disability (Idiocy)
12/2022
1
Suppuration
12/2022
1
Bronchopneumonia
12/2022
1
Type 2 Diabetes Mellitus (MODY)
11/2022
1
Sarcopenia
10/2022
1
Breakthrough Infections
10/2022
1
Anxiety Disorders (Anxiety Disorder)
10/2022
1
Ataxia Telangiectasia (Louis Bar Syndrome)
07/2022
1
Disease Progression
07/2022
1
Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
04/2022
1
Myocarditis (Carditis)
04/2022
1
Alzheimer Disease (Alzheimer's Disease)
02/2022
1
Neuroinflammatory Diseases
02/2022
Drug/Important Bio-Agent (IBA)
8
Proteins (Proteins, Gene)
FDA Link
02/2024 - 09/2015
6
Vaccines
IBA
11/2022 - 12/2020
5
Propofol (Diprivan)
FDA Link
Generic
02/2020 - 01/2011
4
Biomarkers (Surrogate Marker)
IBA
12/2022 - 11/2012
4
Oxygen (Dioxygen)
IBA
12/2022 - 06/2013
3
Phosphotransferases (Kinase)
IBA
05/2024 - 12/2020
3
Adrenal Cortex Hormones (Corticosteroids)
IBA
02/2023 - 01/2022
3
ErbB Receptors (EGF Receptor)
IBA
11/2017 - 08/2012
2
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
05/2024 - 03/2016
2
N-methyl-valyl-amiclenomycin (BA 2)
IBA
03/2024 - 09/2023
2
Antiviral Agents (Antivirals)
IBA
12/2023 - 06/2021
2
G-Protein-Coupled Receptors (Receptors, G Protein Coupled)
IBA
11/2023 - 01/2015
2
Protein Kinases (Protein Kinase)
IBA
10/2022 - 07/2022
2
Messenger RNA (mRNA)
IBA
04/2022 - 06/2015
2
Midazolam (Versed)
FDA Link
Generic
12/2021 - 07/2010
2
Gefitinib (Iressa)
FDA Link
11/2017 - 01/2013
2
Ligands
IBA
03/2016 - 10/2013
2
DNA (Deoxyribonucleic Acid)
IBA
02/2016 - 11/2012
2
Cytokines
IBA
10/2013 - 01/2013
2
Tyrosine Kinase Inhibitors
IBA
01/2013 - 08/2012
1
Taurine
FDA Link
05/2024
1
Hemoglobins (Hemoglobin)
IBA
05/2024
1
Fetal Hemoglobin (Hemoglobin F)
IBA
05/2024
1
Glycogen
IBA
12/2023
1
Colforsin
IBA
12/2023
1
Epinephrine (Adrenaline)
FDA Link
Generic
12/2023
1
Insulin (Novolin)
FDA Link
12/2023
1
Neutralizing Antibodies
IBA
09/2023
1
Angiotensin Receptor Antagonists
IBA
02/2023
1
Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)
IBA
02/2023
1
Antigens
IBA
12/2022
1
Thrombomodulin
IBA
12/2022
1
Uridine
IBA
12/2022
1
pseudouridylate synthetase
IBA
12/2022
1
pseudouridine synthases
IBA
12/2022
1
Metformin (Glucophage)
FDA Link
Generic
11/2022
1
AMP-Activated Protein Kinases
IBA
11/2022
1
Immune Checkpoint Inhibitors
IBA
10/2022
1
Retroelements (Retrotransposon)
IBA
10/2022
1
ginsenoside M1
IBA
07/2022
1
BNT162 Vaccine
IBA
04/2022
1
COVID-19 Vaccines
IBA
04/2022
1
N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamide
IBA
02/2022
1
Inflammasomes
IBA
02/2022
Therapy/Procedure
13
Therapeutics
02/2024 - 01/2011
3
Precision Medicine
06/2023 - 01/2013
3
Length of Stay
02/2023 - 12/2005
3
Continuous Positive Airway Pressure
01/2022 - 06/2013
2
Oral Administration
07/2022 - 02/2022
2
Extracorporeal Membrane Oxygenation
04/2022 - 06/2021
2
Mechanical Ventilators (Ventilator)
06/2021 - 05/2011
2
Lasers (Laser)
01/2020 - 01/2019
1
Duration of Therapy
11/2023
1
Enteral Nutrition (Feeding, Tube)
01/2023
1
Resistance Training
01/2023
1
Traditional Medicine (Folk Remedies)
06/2022